Literature DB >> 18628429

GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese.

Xiuchan Guo1, Stephen J O'Brien, Yi Zeng, George W Nelson, Cheryl A Winkler.   

Abstract

Southern China is a major nasopharyngeal carcinoma-endemic region. Environmental factors and genetic susceptibility contribute to nasopharyngeal carcinoma development in this area. Polymorphic deletions of GSTM1 and GSTT1 genes involved in the detoxification of potentially carcinogenic agents may be a risk factor for nasopharyngeal carcinoma. To investigate the roles of genetic variations of GSTM1 and GSTT1 in nasopharyngeal carcinoma susceptibility in the Chinese population, we conducted a case-control study of 350 nasopharyngeal carcinoma cases and 622 controls. GSTM1 and GSTT1 deletion variants were genotyped by multiplex PCR assays. Logistic regression analysis was used to estimate odds ratios and 95% confidence intervals (95% CI). No significant association was observed for either GSTM1- or GSTT1-null genotype independently in the contribution to nasopharyngeal carcinoma risk. To explore possible joint effects of the GSTM1- and GSTT1-null polymorphisms with each other and with other risk factors for nasopharyngeal carcinoma, we examined the association between each combined genotype and the risk for nasopharyngeal carcinoma stratified by gender and EBV replication status. We found that individuals who carried GSTM1/GSTT1-double null genotype had a higher risk for nasopharyngeal carcinoma in the male population (odds ratio, 1.76; 95% confidence interval, 1.04-2.97; P = 0.03); however, this was not significant after correction for multiple comparisons. No statistical difference was found between cases and controls in females and the subpopulation positive for immunoglobulin A antibodies to EBV capsid antigen for combined genotypes. Our results suggest that the GSTM1/GSTT1-double null genotype may be a risk factor for nasopharyngeal carcinoma among males in southern China, but this result warrants confirmation in other studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628429      PMCID: PMC7370453          DOI: 10.1158/1055-9965.EPI-08-0149

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  22 in total

1.  GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.

Authors:  Joachim Schneider; Ulrike Bernges; Monika Philipp; Hans-Joachim Woitowitz
Journal:  Cancer Lett       Date:  2004-05-10       Impact factor: 8.679

2.  NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

Authors:  Montserrat García-Closas; Núria Malats; Debra Silverman; Mustafa Dosemeci; Manolis Kogevinas; David W Hein; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Gemma Castaño-Vinyals; Meredith Yeager; Robert Welch; Stephen Chanock; Nilanjan Chatterjee; Sholom Wacholder; Claudine Samanic; Montserrat Torà; Francisco Fernández; Francisco X Real; Nathaniel Rothman
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

Review 3.  Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility.

Authors:  T R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-09       Impact factor: 4.254

4.  Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers.

Authors:  I Saadat; M Saadat
Journal:  Cancer Lett       Date:  2001-08-10       Impact factor: 8.679

Review 5.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.

Authors:  J D Hayes; D J Pulford
Journal:  Crit Rev Biochem Mol Biol       Date:  1995       Impact factor: 8.250

6.  Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer.

Authors:  Nurcan Aras Ateş; Lülüfer Tamer; Cengiz Ateş; Bahadir Ercan; Tufan Elipek; Koray Ocal; Handan Camdeviren
Journal:  Biochem Genet       Date:  2005-04       Impact factor: 1.890

7.  Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.

Authors:  Rotraut Mössner; Nils Anders; Inke R König; Ullrich Krüger; Diane Schmidt; Carola Berking; Andreas Ziegler; Jürgen Brockmöller; Rolf Kaiser; Matthias Volkenandt; Götz A Westphal; Kristian Reich
Journal:  Arch Dermatol Res       Date:  2006-10-28       Impact factor: 3.017

8.  Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk.

Authors:  Nady Roodi; William D Dupont; Jason H Moore; Fritz F Parl
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

9.  GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population.

Authors:  Jucimara Colombo; Andréa Regina Baptista Rossit; Alaor Caetano; Aldenis Albaneze Borim; Durval Wornrath; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

10.  Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer.

Authors:  Mia Hashibe; Paul Brennan; Richard C Strange; Rajani Bhisey; Ingolf Cascorbi; Philip Lazarus; Michael B Oude Ophuis; Simone Benhamou; William D Foulkes; Takahiko Katoh; Christiane Coutelle; Marjorie Romkes; Laura Gaspari; Emanuela Taioli; Paolo Boffetta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-12       Impact factor: 4.254

View more
  20 in total

Review 1.  Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.

Authors:  Allan Hildesheim; Cheng-Ping Wang
Journal:  Semin Cancer Biol       Date:  2012-01-25       Impact factor: 15.707

2.  Significant associations between GSTM1/GSTT1 polymorphisms and nasopharyngeal cancer risk.

Authors:  Yumei Wei; Tao Zhou; Haiqun Lin; Mingping Sun; Dongqing Wang; Hongsheng Li; Baosheng Li
Journal:  Tumour Biol       Date:  2012-12-30

3.  Identification of the GST-T1 and GST-M1 null genotypes using high resolution melting analysis.

Authors:  Zuzana Drobná; Luz Maria Del Razo; Gonzalo Garcia-Vargas; Blanca Sánchez-Ramírez; Carmen González-Horta; Lourdes Ballinas-Casarrubias; Dana Loomis; Miroslav Stýblo
Journal:  Chem Res Toxicol       Date:  2011-12-21       Impact factor: 3.739

4.  Quantitative assessment of the association between glutathione S-transferase M1 polymorphism and the risk of developing nasopharyngeal cancer.

Authors:  Yan Zhao; Yubao Wang; Xiaomei Wu; Jun Wang; Lijuan Zhang; Yuchi Jia; Wei Qi
Journal:  Oncol Lett       Date:  2015-10-30       Impact factor: 2.967

5.  A meta-analysis of glutathione S-transferase M1 and T1 genetic polymorphism in relation to susceptibility to nasopharyngeal carcinoma.

Authors:  Rong-Rong Liu; Ji-Chuan Chen; Ming-Dong Li; Te Li; Yun Tan; Min Zhang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  Dysfunction of mitochondria due to environmental carcinogens in nasopharyngeal carcinoma in the ethnic group of Northeast Indian population.

Authors:  Sankar Kumar Ghosh; Anil Seram Singh; Rosy Mondal; Wetetsho Kapfo; V Khamo; Y Indibor Singh
Journal:  Tumour Biol       Date:  2014-04-09

7.  Association of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta-analysis.

Authors:  Muyun Wu; Shujing Huang; Dong Liu; Miao Peng; Fan Yang; Xicheng Wang
Journal:  Mol Clin Oncol       Date:  2015-12-08

8.  Glutathione S-transferase M1 and T1 null genotype frequency distribution among four tribal populations of western India.

Authors:  Prem Chandra Suthar; Pulakes Purkait; Kiran Uttaravalli; B N Sarkar; Rakshit Ameta; Mithun Sikdar
Journal:  J Genet       Date:  2018-03       Impact factor: 1.166

9.  Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China.

Authors:  Xiuchan Guo; Randall C Johnson; Hong Deng; Jian Liao; Li Guan; George W Nelson; Mingzhong Tang; Yuming Zheng; Guy de The; Stephen J O'Brien; Cheryl A Winkler; Yi Zeng
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

10.  Knockdown of LMP1-induced miR-155 sensitizes nasopharyngeal carcinoma cells to radiotherapy in vitro.

Authors:  Yusheng Wang; L E Sun
Journal:  Oncol Lett       Date:  2016-03-31       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.